Stereotaxis market cap STXS

Share price times shares outstanding: what the whole company sells for, since 2011.

Stereotaxis is worth $102.2M at the close on Oct 23, 2026, at $1.02 a share.

That is down 64% over the last year and down 77% over five years.

Its highest close in our data was $721.1M in Jun 2021.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$102.2M	$101.2M	$250.1M	−55%
2025	$229.6M	$142.7M	$284.7M	+18%
2024	$194M	$140.7M	$262.8M	+37%
2023	$141.5M	$116.5M	$199.1M	−9%
2022	$154.9M	$122.7M	$459.4M	−66%
2021	$462.4M	$344.1M	$721.1M	+23%
2020	$375.1M	$174M	$382.4M	+12%
2019	$335.6M	$70.6M	$340.9M	+394%
2018	$67.9M	$15.3M	$93.3M	+272%
2017	$18.2M	$12.4M	$22.8M	+28%
2016	$14.2M	$11.8M	$36.5M	−11%
2015	$16M	$16M	$54.2M	−46%
2014	$29.5M	$28M	$92.4M	−51%
2013	$60.1M	$10.3M	$63.6M	+207%
2012	$19.6M	$7.7M	$42M	−53%
2011	$41.7M	$41.7M	$71.8M	n/a

Companies in Healthcare nearest Stereotaxis' size, closest first, today.

Company	Market cap
STXSStereotaxis	$102.2M
KEQUKewaunee Scientific	$94.9M
ICCCImmucell	$93.1M
LFVNLifevantage	$73.4M
SPROSpero Therapeutics	$64.6M
APTAlpha Pro Tech	$56.7M
PDEXPro DEX	$199.3M
PLXProtalix BioTherapeutics	$205.5M
NATRNatures Sunshine Products	$213.8M
ATNMActinium Pharmaceuticals	$47.8M
ELMDElectromed	$220.6M
Peer median	$94M